Medicinal inhalation aerosol formulations containing budesonide
US6039932A · kind A · utility
20Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1997 |
| Grant date | Mar 21, 2000 |
| Priority date | — |
| Expiry date | Sep 25, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical aerosol formulation, suitable for administration by oral or nasal inhalation, containing a suspension of particulate budesonide, hydrofluoroalkane propellant and, optionally, additional hydrofluoroalkane propellants, surfactant selected from oleic acid, sorbitan oleates and lecithin, and adjuvant have a Kauri-butanol value of at least 10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.